John Sherwin - Search Results

Year	Number of Results
2004	1
2006	3
2010	3
2011	2
2013	1
2019	1
2024	0

1

Krantz DA, Hallahan TW, Sherwin JE. Krantz DA, et al. Among authors: sherwin je. Clin Lab Med. 2010 Sep;30(3):721-5. doi: 10.1016/j.cll.2010.04.010. Epub 2010 Jun 15. Clin Lab Med. 2010. PMID: 20638584 Review.

2

First-trimester screening in triplets.

Krantz DA, Hallahan TW, He K, Sherwin JE, Evans MI. Krantz DA, et al. Among authors: sherwin je. Am J Obstet Gynecol. 2011 Oct;205(4):364.e1-5. doi: 10.1016/j.ajog.2011.06.107. Epub 2011 Aug 27. Am J Obstet Gynecol. 2011. PMID: 22083057

3

Patient and public involvement in biomedical research: training is not a substitute for relationship building.

Wilson AG, Sherwin J, Dorris ER. Wilson AG, et al. Among authors: sherwin j. Ann Rheum Dis. 2019 Nov;78(11):1607-1608. doi: 10.1136/annrheumdis-2019-215595. Epub 2019 Jul 12. Ann Rheum Dis. 2019. PMID: 31300462 No abstract available.

4

Undermeasurement of nuchal translucencies: implications for screening.

Evans MI, Krantz DA, Hallahan TW, Sherwin JE. Evans MI, et al. Among authors: sherwin je. Obstet Gynecol. 2010 Oct;116(4):815-818. doi: 10.1097/AOG.0b013e3181f23ae3. Obstet Gynecol. 2010. PMID: 20859143

5

Newborn Screening System Performance Evaluation Assessment Scheme (PEAS).

Therrell BL Jr, Schwartz M, Southard C, Williams D, Hannon WH, Mann MY; PEAS Organizing and Working Groups. Therrell BL Jr, et al. Semin Perinatol. 2010 Apr;34(2):105-20. doi: 10.1053/j.semperi.2009.12.002. Semin Perinatol. 2010. PMID: 20207260

6

Pilot programs in newborn screening.

Pass K, Green NS, Lorey F, Sherwin J, Comeau AM. Pass K, et al. Among authors: sherwin j. Ment Retard Dev Disabil Res Rev. 2006;12(4):293-300. doi: 10.1002/mrdd.20122. Ment Retard Dev Disabil Res Rev. 2006. PMID: 17183570

7

Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease.

Kroll CA, Ferber MJ, Dawson BD, Jacobson RM, Mensink KA, Lorey F, Sherwin J, Cunningham G, Rinaldo P, Matern D, Hahn SH. Kroll CA, et al. Among authors: sherwin j. Mol Genet Metab. 2006 Sep-Oct;89(1-2):134-8. doi: 10.1016/j.ymgme.2006.03.008. Epub 2006 Apr 27. Mol Genet Metab. 2006. PMID: 16644258

8

California's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry.

Feuchtbaum L, Lorey F, Faulkner L, Sherwin J, Currier R, Bhandal A, Cunningham G. Feuchtbaum L, et al. Among authors: sherwin j. Pediatrics. 2006 May;117(5 Pt 2):S261-9. doi: 10.1542/peds.2005-2633E. Pediatrics. 2006. PMID: 16735252

9

Quality of nuchal translucency measurements correlates with broader aspects of program rigor and culture of excellence.

Evans MI, Krantz DA, Hallahan T, Sherwin J, Britt DW. Evans MI, et al. Among authors: sherwin j. Fetal Diagn Ther. 2013;33(4):230-4. doi: 10.1159/000346418. Epub 2013 Mar 14. Fetal Diagn Ther. 2013. PMID: 23548741

10

Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients.

Alper OM, Wong LJ, Young S, Pearl M, Graham S, Sherwin J, Nussbaum E, Nielson D, Platzker A, Davies Z, Lieberthal A, Chin T, Shay G, Hardy K, Kharrazi M. Alper OM, et al. Among authors: sherwin j. Hum Mutat. 2004 Oct;24(4):353. doi: 10.1002/humu.9281. Hum Mutat. 2004. PMID: 15365999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year